The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Amlodipine Besylate Market Research Report 2024

Global Amlodipine Besylate Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1804416

No of Pages : 115

Ask Your Query
Synopsis
Amlodipine Besylate is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: Hypertension and Coronary Artery Disease.
The global Amlodipine Besylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amlodipine Besylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amlodipine Besylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amlodipine Besylate include Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma and Upsher-Smith Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amlodipine Besylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amlodipine Besylate.
Report Scope
The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amlodipine Besylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Mylan
Dr. Reddy's Laboratories
Apotex
Teva Pharmaceutical
Cipla
Hikma Pharmaceuticals
Strides Pharma
Upsher-Smith Laboratories
InvaGen Pharmaceuticals
Sun Pharmaceutical
Aurobindo Pharma
Lupin Pharmaceuticals
Zydus Pharmaceuticals
Oxford Pharm
Wockhardt
Epic Pharma
CR Pharmaceutical
Alkem Laboratories
MACLEODS
Segment by Type
2.5mg Tablets
5mg Tablets
10mg Tablets
Segment by Application
High Blood Pressure
Heart Disease
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amlodipine Besylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amlodipine Besylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Amlodipine Besylate Market Overview
1.1 Product Overview and Scope of Amlodipine Besylate
1.2 Amlodipine Besylate Segment by Type
1.2.1 Global Amlodipine Besylate Market Value Comparison by Type (2024-2030)
1.2.2 2.5mg Tablets
1.2.3 5mg Tablets
1.2.4 10mg Tablets
1.3 Amlodipine Besylate Segment by Application
1.3.1 Global Amlodipine Besylate Market Value by Application: (2024-2030)
1.3.2 High Blood Pressure
1.3.3 Heart Disease
1.4 Global Amlodipine Besylate Market Size Estimates and Forecasts
1.4.1 Global Amlodipine Besylate Revenue 2019-2030
1.4.2 Global Amlodipine Besylate Sales 2019-2030
1.4.3 Global Amlodipine Besylate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amlodipine Besylate Market Competition by Manufacturers
2.1 Global Amlodipine Besylate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amlodipine Besylate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amlodipine Besylate Average Price by Manufacturers (2019-2024)
2.4 Global Amlodipine Besylate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amlodipine Besylate, Product Type & Application
2.7 Amlodipine Besylate Market Competitive Situation and Trends
2.7.1 Amlodipine Besylate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amlodipine Besylate Players Market Share by Revenue
2.7.3 Global Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amlodipine Besylate Retrospective Market Scenario by Region
3.1 Global Amlodipine Besylate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amlodipine Besylate Global Amlodipine Besylate Sales by Region: 2019-2030
3.2.1 Global Amlodipine Besylate Sales by Region: 2019-2024
3.2.2 Global Amlodipine Besylate Sales by Region: 2025-2030
3.3 Global Amlodipine Besylate Global Amlodipine Besylate Revenue by Region: 2019-2030
3.3.1 Global Amlodipine Besylate Revenue by Region: 2019-2024
3.3.2 Global Amlodipine Besylate Revenue by Region: 2025-2030
3.4 North America Amlodipine Besylate Market Facts & Figures by Country
3.4.1 North America Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amlodipine Besylate Sales by Country (2019-2030)
3.4.3 North America Amlodipine Besylate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amlodipine Besylate Market Facts & Figures by Country
3.5.1 Europe Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amlodipine Besylate Sales by Country (2019-2030)
3.5.3 Europe Amlodipine Besylate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amlodipine Besylate Market Facts & Figures by Country
3.6.1 Asia Pacific Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amlodipine Besylate Sales by Country (2019-2030)
3.6.3 Asia Pacific Amlodipine Besylate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amlodipine Besylate Market Facts & Figures by Country
3.7.1 Latin America Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amlodipine Besylate Sales by Country (2019-2030)
3.7.3 Latin America Amlodipine Besylate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amlodipine Besylate Market Facts & Figures by Country
3.8.1 Middle East and Africa Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amlodipine Besylate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amlodipine Besylate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amlodipine Besylate Sales by Type (2019-2030)
4.1.1 Global Amlodipine Besylate Sales by Type (2019-2024)
4.1.2 Global Amlodipine Besylate Sales by Type (2025-2030)
4.1.3 Global Amlodipine Besylate Sales Market Share by Type (2019-2030)
4.2 Global Amlodipine Besylate Revenue by Type (2019-2030)
4.2.1 Global Amlodipine Besylate Revenue by Type (2019-2024)
4.2.2 Global Amlodipine Besylate Revenue by Type (2025-2030)
4.2.3 Global Amlodipine Besylate Revenue Market Share by Type (2019-2030)
4.3 Global Amlodipine Besylate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amlodipine Besylate Sales by Application (2019-2030)
5.1.1 Global Amlodipine Besylate Sales by Application (2019-2024)
5.1.2 Global Amlodipine Besylate Sales by Application (2025-2030)
5.1.3 Global Amlodipine Besylate Sales Market Share by Application (2019-2030)
5.2 Global Amlodipine Besylate Revenue by Application (2019-2030)
5.2.1 Global Amlodipine Besylate Revenue by Application (2019-2024)
5.2.2 Global Amlodipine Besylate Revenue by Application (2025-2030)
5.2.3 Global Amlodipine Besylate Revenue Market Share by Application (2019-2030)
5.3 Global Amlodipine Besylate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Amlodipine Besylate Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Amlodipine Besylate Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Reddy's Laboratories Amlodipine Besylate Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Amlodipine Besylate Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Corporation Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Amlodipine Besylate Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Amlodipine Besylate Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hikma Pharmaceuticals Amlodipine Besylate Product Portfolio
6.7.5 Hikma Pharmaceuticals Recent Developments/Updates
6.8 Strides Pharma
6.8.1 Strides Pharma Corporation Information
6.8.2 Strides Pharma Description and Business Overview
6.8.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Strides Pharma Amlodipine Besylate Product Portfolio
6.8.5 Strides Pharma Recent Developments/Updates
6.9 Upsher-Smith Laboratories
6.9.1 Upsher-Smith Laboratories Corporation Information
6.9.2 Upsher-Smith Laboratories Description and Business Overview
6.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Upsher-Smith Laboratories Amlodipine Besylate Product Portfolio
6.9.5 Upsher-Smith Laboratories Recent Developments/Updates
6.10 InvaGen Pharmaceuticals
6.10.1 InvaGen Pharmaceuticals Corporation Information
6.10.2 InvaGen Pharmaceuticals Description and Business Overview
6.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 InvaGen Pharmaceuticals Amlodipine Besylate Product Portfolio
6.10.5 InvaGen Pharmaceuticals Recent Developments/Updates
6.11 Sun Pharmaceutical
6.11.1 Sun Pharmaceutical Corporation Information
6.11.2 Sun Pharmaceutical Amlodipine Besylate Description and Business Overview
6.11.3 Sun Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sun Pharmaceutical Amlodipine Besylate Product Portfolio
6.11.5 Sun Pharmaceutical Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Amlodipine Besylate Description and Business Overview
6.12.3 Aurobindo Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Aurobindo Pharma Amlodipine Besylate Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Lupin Pharmaceuticals
6.13.1 Lupin Pharmaceuticals Corporation Information
6.13.2 Lupin Pharmaceuticals Amlodipine Besylate Description and Business Overview
6.13.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lupin Pharmaceuticals Amlodipine Besylate Product Portfolio
6.13.5 Lupin Pharmaceuticals Recent Developments/Updates
6.14 Zydus Pharmaceuticals
6.14.1 Zydus Pharmaceuticals Corporation Information
6.14.2 Zydus Pharmaceuticals Amlodipine Besylate Description and Business Overview
6.14.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zydus Pharmaceuticals Amlodipine Besylate Product Portfolio
6.14.5 Zydus Pharmaceuticals Recent Developments/Updates
6.15 Oxford Pharm
6.15.1 Oxford Pharm Corporation Information
6.15.2 Oxford Pharm Amlodipine Besylate Description and Business Overview
6.15.3 Oxford Pharm Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Oxford Pharm Amlodipine Besylate Product Portfolio
6.15.5 Oxford Pharm Recent Developments/Updates
6.16 Wockhardt
6.16.1 Wockhardt Corporation Information
6.16.2 Wockhardt Amlodipine Besylate Description and Business Overview
6.16.3 Wockhardt Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Wockhardt Amlodipine Besylate Product Portfolio
6.16.5 Wockhardt Recent Developments/Updates
6.17 Epic Pharma
6.17.1 Epic Pharma Corporation Information
6.17.2 Epic Pharma Amlodipine Besylate Description and Business Overview
6.17.3 Epic Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Epic Pharma Amlodipine Besylate Product Portfolio
6.17.5 Epic Pharma Recent Developments/Updates
6.18 CR Pharmaceutical
6.18.1 CR Pharmaceutical Corporation Information
6.18.2 CR Pharmaceutical Amlodipine Besylate Description and Business Overview
6.18.3 CR Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.18.4 CR Pharmaceutical Amlodipine Besylate Product Portfolio
6.18.5 CR Pharmaceutical Recent Developments/Updates
6.19 Alkem Laboratories
6.19.1 Alkem Laboratories Corporation Information
6.19.2 Alkem Laboratories Amlodipine Besylate Description and Business Overview
6.19.3 Alkem Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Alkem Laboratories Amlodipine Besylate Product Portfolio
6.19.5 Alkem Laboratories Recent Developments/Updates
6.20 MACLEODS
6.20.1 MACLEODS Corporation Information
6.20.2 MACLEODS Amlodipine Besylate Description and Business Overview
6.20.3 MACLEODS Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.20.4 MACLEODS Amlodipine Besylate Product Portfolio
6.20.5 MACLEODS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amlodipine Besylate Industry Chain Analysis
7.2 Amlodipine Besylate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amlodipine Besylate Production Mode & Process
7.4 Amlodipine Besylate Sales and Marketing
7.4.1 Amlodipine Besylate Sales Channels
7.4.2 Amlodipine Besylate Distributors
7.5 Amlodipine Besylate Customers
8 Amlodipine Besylate Market Dynamics
8.1 Amlodipine Besylate Industry Trends
8.2 Amlodipine Besylate Market Drivers
8.3 Amlodipine Besylate Market Challenges
8.4 Amlodipine Besylate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock